Presenting features of patients with CNS relapse
Patient no. . | Age, y . | Sex . | Leukocyte count, × 109/L . | Immunophenotype . | Genotype . | CNS status . |
|---|---|---|---|---|---|---|
| Isolated CNS relapse | ||||||
| 1 | 2 | Male | 565 | B-cell precursor | Pseudodiploid | CNS-2 |
| 2 | 6 | Male | 23.5 | T-cell | Pseudodiploid | CNS-2 |
| 3 | 7 | Male | 8 | B-cell precursor | Hyperdiploid > 50 | CNS-1 |
| 4 | 9 | Male | 2.4 | B-cell precursor | Near-haploid | CNS-2 |
| Combined CNS relapse | ||||||
| 5 | 5 | Male | 367.5 | T-cell | Normal | CNS-2 |
| 6 | 5 | Female | 6.8 | B-cell precursor | Hyperdiploid > 50 | CNS-1 |
| 7 | 13 | Male | 10.9 | B-cell precursor | — | CNS-1 |
| 8 | 13 | Male | 48.2 | T-cell | Pseudodiploid | CNS-1 |
Patient no. . | Age, y . | Sex . | Leukocyte count, × 109/L . | Immunophenotype . | Genotype . | CNS status . |
|---|---|---|---|---|---|---|
| Isolated CNS relapse | ||||||
| 1 | 2 | Male | 565 | B-cell precursor | Pseudodiploid | CNS-2 |
| 2 | 6 | Male | 23.5 | T-cell | Pseudodiploid | CNS-2 |
| 3 | 7 | Male | 8 | B-cell precursor | Hyperdiploid > 50 | CNS-1 |
| 4 | 9 | Male | 2.4 | B-cell precursor | Near-haploid | CNS-2 |
| Combined CNS relapse | ||||||
| 5 | 5 | Male | 367.5 | T-cell | Normal | CNS-2 |
| 6 | 5 | Female | 6.8 | B-cell precursor | Hyperdiploid > 50 | CNS-1 |
| 7 | 13 | Male | 10.9 | B-cell precursor | — | CNS-1 |
| 8 | 13 | Male | 48.2 | T-cell | Pseudodiploid | CNS-1 |